Pharmacy Medical News about gastroduodenal damage

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage
Journal of Gastroenterology and Hepatology, 08/11/09

Lim YJ et al. – Recent advances in basic science and biotechnology have given insights into molecular mechanisms of NSAID–induced gastroduodenal damage beyond COX–2 inhibition. The emergence of newer kinds of NSAIDs should alleviate gastroduodenal toxicity without compromising innate drug efficacy.

<< Previous
Intravenous therapy for hypertensive emergencies, part 2

Next >>
Carbamazepine-induced hyperammonemia

Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs
Current Medical Research and Opinion, 10/01/09 Relevance Score: 65%

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells
BMC Cancer, 10/15/09 Relevance Score: 46%

Oxidative DNA damage in chronic renal failure patients
Nephrology Dialysis Transplantation, 11/05/09 Relevance Score: 45%

RoACTEMRA filed in Europe for the Inhibition of Joint Damage and Improvement in Physical Function in Rheumatoid Arthritis
Chugai Pharmaceutical Co., 10/16/09 Relevance Score: 45%

RoACTEMRA filed in Europe for the Inhibition of Joint Damage and Improvement in Physical Function in Rheumatoid Arthritis
Chugai Pharmaceutical Co., 10/14/09 Relevance Score: 45%